These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 25369308)
1. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases. Dhingra S; Schwartz M; Kim E; Mabel Ko H; Ward SC; Fiel MI; Thung SN Semin Liver Dis; 2014 Nov; 34(4):465-8. PubMed ID: 25369308 [TBL] [Abstract][Full Text] [Related]
2. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma. Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S; J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371 [TBL] [Abstract][Full Text] [Related]
4. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma. Gabr A; Abouchaleh N; Ali R; Baker T; Caicedo J; Katariya N; Abecassis M; Riaz A; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2018 Nov; 29(11):1502-1510.e1. PubMed ID: 30268638 [TBL] [Abstract][Full Text] [Related]
7. Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres. Hamoui N; Minocha J; Memon K; Sato K; Ryu R; Salem R; Lewandowski RJ J Vasc Interv Radiol; 2013 Nov; 24(11):1743-5. PubMed ID: 24160828 [No Abstract] [Full Text] [Related]
8. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe. Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039 [TBL] [Abstract][Full Text] [Related]
9. Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres. Li MD; Chu KF; DePietro A; Wu V; Wehrenberg-Klee E; Zurkiya O; Liu RW; Ganguli S J Vasc Interv Radiol; 2019 Mar; 30(3):314-319. PubMed ID: 30819470 [TBL] [Abstract][Full Text] [Related]
10. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma]. Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369 [TBL] [Abstract][Full Text] [Related]
14. Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center. Piana PM; Gonsalves CF; Sato T; Anne PR; McCann JW; Bar Ad V; Eschelman DJ; Parker L; Doyle LA; Brown DB J Vasc Interv Radiol; 2011 Oct; 22(10):1373-9. PubMed ID: 21764600 [TBL] [Abstract][Full Text] [Related]
15. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574 [TBL] [Abstract][Full Text] [Related]
16. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres. Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957 [TBL] [Abstract][Full Text] [Related]
17. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987 [TBL] [Abstract][Full Text] [Related]
18. Microvascular injury in persistent gastric ulcers after yttrium-90 microsphere radioembolization for liver malignancies. Sun B; Lapetino SR; Diffalha SA; Yong S; Gaba RC; Bui JT; Koppe S; Garzon S; Guzman G Hum Pathol; 2016 Apr; 50():11-4. PubMed ID: 26997433 [TBL] [Abstract][Full Text] [Related]
19. Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma. Johnson GE; Monsky WL; Valji K; Hippe DS; Padia SA J Vasc Interv Radiol; 2016 Aug; 27(8):1123-9. PubMed ID: 27321889 [TBL] [Abstract][Full Text] [Related]
20. Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series. Rose SC; Narsinh KH; Newton IG J Vasc Interv Radiol; 2017 Jan; 28(1):103-110. PubMed ID: 27840042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]